Bones play crucial roles in motility, electrolyte metabolism, and immunity. Clinical cases have suggested bone dysfunction in several systemic autoimmune diseases. This study exhibited altered bone morpho-functions in BXSB/MpJ-Yaa as a murine autoimmune disease model. During clinical examinations, the serum Ca level was significantly higher in BXSB/MpJ-Yaa than the healthy control BXSB/MpJ at the early stage (two to four months), but that in BXSB/MpJ-Yaa decreased with advancing age. Further, the increase of urinary Ca with nephritis and white blood cells with mild anemia proceeded in BXSB/MpJYaa with advancing age. The thyroid and parathyroid gland morphologies and serum parathormone level did not differ among strains, but the tibia was smaller in BXSB/MpJ-Yaa than in BXSB/MpJ especially during the late stage (six months). Histologically, osteoclasts and osteoblasts showed increased and decreased tendencies, respectively, in BXSB/MpJYaa during the early stage, and osteoclasts and bone area significantly increased and decreased, respectively, compared with BXSB/MpJ at later stages. The bone morphological indices were affected by the expression of BXSB/MpJ-Yaa mutation genes and inflammatory genes in BXSB/MpJ-Yaa. In conclusion, systemic autoimmune diseases in BXSB/ MpJ-Yaa are associated with the morpho-functional abnormalities of bones, calcium dynamics, and hematopoiesis, and each factor contributes to forming the phenotypes in this disease.
Introduction
Bones play various roles, such as assisting motor function and electrolyte metabolism of circulating calcium or phosphorus. Additionally, the bone marrow (BM), a primary lymphatic organ located deep in the bone, plays a crucial role in immunity. To date, the bone and BM have been considered different and unrelated organs owing to the differences in their development and functions. However, recently, the osteoblasts responsible for bone formation were shown to participate in the production of hematopoietic stem and progenitor cells (HSPCs) in mice. 1 Moreover, osteoclast precursor cells and osteoblasts expressed tumor necrosis factor receptor superfamily, member 11a, nuclear
Impact statement
Bone disease, such as osteoporosis and rheumatoid arthritis, increases because of the progression of an aging society. Autoimmune disease are important and predisposing factors for the pathogenesis of the bone disease; however, the pathological mechanism is unclear. We have demonstrated that systemic autoimmune disease in BXSB/MpJ-Yaa is closely associated with the morpho-functional abnormalities of bones including bone marrow and has complicated pathology. The abnormalities are characterized by altered regulations of serum calcium, anemia tendency, and hematopoiesis with increased WBCs and decreased PLs, short length and low mass of long bones, imbalance in the populations of osteoclasts and osteoblasts, and increased expression of candidate genes for causing and/or exacerbating their phenotypes. Therefore, BXSB/MpJ-Yaa serves as a model to elucidate bone phenotypes in systemic autoimmune disease that would be affected by the factors in the bone as well as the other immune and/or mineral metabolism organs both in human and experimental medicine.
factor kappa B (NFrB) activator (Tnfrsf11a/RANK), and tumor necrosis factor (ligand) superfamily, member 11 (Tnfsf11/RANKL), respectively. 2 This cell to cell contact via RANK/RANKL interaction was important for the differentiation of mouse osteoclast precursor cells into mature osteoclasts. 2 Alternatively, RANKL expression was identified in T-cells. It regulates interactions between T-cells and dendritic cells, maturing dendritic cells, and lymph node organogenesis in humans. 3, 4 The functional imbalance of osteoblasts and osteoclasts causes bone-related diseases such as osteoporosis in humans, and their incidents increase because of the progression of an aging society. 5, 6 Osteoporosis and osteopetrosis are associated with the hyper-activation and dysfunction of osteoclasts causing the decrease and increase in bone density, respectively. 6, 7 Particularly, aging and altered immune conditions are important and predisposing factors for the pathogenesis of osteoporosis. Rheumatoid arthritis (RA), a bone-related autoimmune disease in humans, causes chronic inflammation characterized by secondary osteoporosis and synovitis, joint swelling, and destruction of cartilage and bone. 8, 9 RA patients develop motor impairment with arthralgia, and bone destruction that could be induced by the actions of T helper 1 (Th1)-cells, Th17-cells, B-cells, and produced cytokines, such as tumor necrosis factor a (TNF-a), interleukin 1 (IL-1), and IL-6. 8, [10] [11] [12] [13] Thus, crucial correlations between the bone and immune system based on osteoimmunology, and their alternations would contribute to their bidirectional pathogenesis.
For the diagnosis and evaluation of bone-related diseases, blood electrolyte examination, targeting Ca and phosphorus, is useful. However, their blood concentration does not completely reflect bone conditions. Blood Ca concentration is regulated by various organs such as bones, thyroid glands, parathyroid glands, kidneys, and intestines with regard to absorption and excretion. 14, 15 During the dysfunction of Ca-regulating organs, its blood concentration would be changed. Although the chronic kidney disease (CKD) patients exhibited hypocalcemia and hyperphosphatemia due to impaired renal functions, these imbalances are compensated by an increased activity of parathyroid hormone (PTH). However, with the progression of CKD, PTH cannot control the blood Ca, which shows significant decrease. 16 Further, vitamin D obtained through food, produced in the skin, and activated in the kidney, is related to osteogenesis by increasing blood Ca level.
14 Vitamin D also associates with the immune function and its abnormality. Patients with autoimmune diseases, such as systemic lupus erythematosus (SLE) and RA, have low levels of vitamin D in the blood, contributing to osteoporosis. 17 Furthermore, the blood mineral levels show complex dynamics and do not necessarily represent the state of bones in several diseases. Therefore, the combination of morphological evaluations of bones and blood examinations is essential to understand the pathogenesis of bone-related diseases in the patients suffering the other disease.
To understand the effect of autoimmune diseases on bone morphology, we histopathologically examined the phenotype of BXSB/MpJ-Yaa (BXSB-Yaa) mice as an autoimmune disease model. As BXSB-Yaa carries the Y-linked autoimmune accelerator (Yaa) mutation on the Y chromosome, the male mice develop severe autoimmune symptoms similar to SLE characterized by abnormal proliferation of B-cells, auto-antibody production, and splenomegaly, 18, 19 but not RA. 20 We have already demonstrated the pathological features of nephritis and dacryoadenitis in BXSB-Yaa, [21] [22] [23] however, its bone morphology was unclear. Therefore, we analyzed the altered bone structures, especially focusing on the population of osteoblasts and osteoclasts, by comparisons between BXSB-Yaa and its control strain BXSB/MpJ (BXSB) with the evaluation of blood mineral dynamics and autoimmune disease conditions.
Material and methods

Animal ethics
Animal experimentation was approved by the Institutional Animal Care and Use Committee of the Graduate of School of Veterinary Medicine, Hokkaido University (approval no. . The animals were handled in accordance with the Guide for the Care and Use of Laboratory Animals, Graduate School of Veterinary Medicine, Hokkaido University (approved by the Association for Assessment and Accreditation of Laboratory Animal Care International). Male BXSB and BXSB-Yaa aged two to six months were purchased from Japan SLC, Inc. (Hamamatsu, Japan) and were maintained under specific pathogen-free conditions. Blood of all mice were collected from femoral arteries under deep anesthesia using the mixture of medetomidine (0.3 mg/kg), midazolam (4 mg/kg), and butorphanol (5 mg/kg). Finally, all mice were euthanized by cervical dislocation.
Hematological and serological analysis and urinalysis
The number of white blood cells (WBCs), red blood cells (RBCs), platelets (PLs), hemoglobin concentration (HC), hematocrit volume (Ht), mean corpuscular volume (MCV), and mean corpuscular HC (MCHC) was measured using a XT-1800i instrument (Sysmex Corporation, Kobe, Japan). Additionally, the blood smear was stained by Diff-Quik solution (Sysmex Corporation) to detect reticulocytes.
Serum levels of anti-double strand DNA (dsDNA) antibody were measured to evaluate systemic autoimmune conditions using LBIS Anti dsDNA-Mouse ELISA Kit (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) according to the manufacturer's instructions. As an index of mineral metabolism of bones, the serum Ca concentration was measured using a Fuji Dri-Chem 7000v instrument (FUJIFILM Medical Co., Ltd., Tokyo, Japan). Furthermore, urinary concentrations of Ca and creatinine (CRE) were determined by a Fuji Dri-Chem 7000v instrument (FUJIFILM Medical Co., Ltd.) and Creatinine-testWako (FUJIFILM Wako Pure Chemical Corporation) according to the manufacturer's instructions. Serum PTH concentration was measured to evaluate parathyroid gland function using Mouse PTH 1-84 ELISA kit (Quidel Corporation, San Diego, CA, USA).
Morphological and histological analyses of bones
To evaluate the gross morphology of bones, the bone length and wet weight were measured. After taking a picture of the tibia, the tibia length was measured by ImageJ. 24 Subsequently, the ratio of tibia and fibula weight to body weight (BW) was calculated.
The tibia samples for histology were fixed with 4% paraformaldehyde at 4 C overnight, and decalcified by 5% ethylenediaminetetraacetic acid at 4 C for 5 days. After decalcification, the specimens were routinely dehydrated by ethanol and embedded into paraffin. Then, paraffin sections (3 mm) were prepared and stained with hematoxylin and eosin (HE) or tartrate-resistant acid phosphatase (TRAP) staining Kit (FUJIFILM Wako Pure Chemical Corporation) to detect the osteoclasts.
Immunohistochemistry
The paraffin sections were immunostained using the methodology by a previous study. 23 The antigen retrieval was applied to sections (Supplementary Table 1 ). Subsequently, to block internal peroxidase activity, the sections were soaked in methanol containing 0.3% H 2 O 2 for 20 minutes at 25 C. After washing three times in phosphate-buffered saline (PBS), the sections were incubated with a blocking serum for 1 h at 25 C to block the non-specific sites. Then, sections were incubated with primary antibodies overnight at 4 C. The sections were then washed thrice in PBS and incubated with secondary antibodies for 30 minutes at 25 C and washed thrice in PBS. Consequently, the sections were incubated with streptavidin conjugated horseradish peroxidase (SABPO(R) kit, Nichirei; Tokyo, Japan) for 30 minutes at 25 C, washed three times in PBS, and the immunopositive reaction was visualized with 3,3 0 -diaminobenzidine tetrahydrochloride-H 2 O 2 solution. Finally, the sections were lightly stained with hematoxylin. The details of the antibody, antigen retrieval, and blocking are listed in Supplementary Table 1 .
Histoplanimetry
We performed the histoplanimetrical analysis of tibias using histological stained sections as shown in Supplementary Figure 1 . We evaluated the area ratio of bone to BM, the ratio of trabecular area to tissue area (Tb. Ar/T.Ar), trabecular width (Tb.Wi), trabecular number (Tb. N), trabecular separation (Tb.Sp), TRAP þ cells with 2 or more nuclei, as osteoclasts, osteocalcin þ cells, osteoblasts, and osteocytes. 25, 26 Quantitative polymerase chain reaction Total RNA from the bone including BM in a humerus was purified using the TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer's instructions. The purified total RNA (83.3 ng/ml) was treated as a template to synthesize cDNA using ReverTra Ace qPCR RT Master Mix (Toyobo Co., Ltd., Osaka, Japan). Quantitative polymerase chain reaction (qPCR) analysis was performed on the cDNA (20 ng/ml) using THUNDERBIRD V R SYBR V R qPCR Mix (Toyobo Co., Ltd.) and the following genespecific primers (Supplementary Table 2 ). The qPCR cycling conditions were: 95 C for 1 min, (95 C for 15 s, 60 C for 45 s (40 cycles)). Data were normalized by the values of actin, beta (Actb), and those of BXSB at three months using the delta-delta Ct method.
Statistical analysis
The data were expressed as the mean AE standard error (SE) and statistically analyzed by a non-parametric manner. Briefly, the significance between the two groups was analyzed by the Mann-Whitney U-test (P < 0.05). The correlation between the two parameters was analyzed using Spearman's correlation test (P < 0.05).
Results
Autoimmune disease features found in BXSB-Yaa
We pathologically examined mice at three and six months of age ( Figure 1 ). The BW in BXSB-Yaa was lower than in BXSB at both ages, and that of BXSB significantly increased with advancing age, but not in BXSB-Yaa (Figure 1(a) ). Regarding autoimmune disease indices, BXSB-Yaa showed significantly higher values in the ratio of spleen weight to BW (S/B) and the serum levels of anti-dsDNA antibody compared with BXSB at both ages ( Figure 1 (b) and (c)). Further, for S/B, BXSB-Yaa at six months significantly showed higher values than those at three months ( Figure 1(b) ). Thus, autoimmune disease phenotypes were evident in BXSB-Yaa and deteriorated at six months.
Impaired bone metabolism, renal function, and hematopoiesis in BXSB-Yaa
Considering bone metabolism indices, the serum level of Ca was significantly higher in BXSB-Yaa than in BXSB at two to four months, and that of the former was significantly decreased with advancing age (Figure 1(d) ), indicating the imbalanced Ca metabolism in BXSB-Yaa. For the ratio of urinary Ca to CRE level, an indicator of urinary Ca excretion, the BXSB-Yaa at six months showed the highest value, and significant differences were observed between three and six months in this strain (Figure 1(e) ). Although we hypothesized secondary hyperparathyroidism in BXSBYaa at six months due to nephritis, 14 neither significant age-nor strain-related change was observed in the serum PTH concentration (Figure 1(f) ).
Furthermore, we performed hematological and serological analyses, focusing on hematopoiesis including, counts of WBCs, RBCs, PLs (Figure 1 There was no significant age-or strain-related change in the other parameters. Further, at six months, the reticulocytes were more abundant in BXSB-Yaa than in BXSB (Figure 1(n) ).
We also histologically examined the organs, such as kidneys, thyroid and parathyroid glands, involved in the regulation of blood Ca concentration (Figure 2(a) to (c) ). For renal histopathology, severe glomerulonephritis with immune cell infiltrations to the tubulointerstitium was observed in the kidney of BXSB-Yaa at six months as described previously, 21 but that was not clearly observed in BXSB at both ages and BXSB-Yaa at three months (Figure 2(a) ). The injured kidney in BXSB-Yaa at six months coincided with increase in urinary Ca level (as shown in Figure 1(e) ). In thyroid glands, histopathological changes such as dilation of follicle or inflammation were not observed in all examined mice (Figure 2(b) ).
Further, the localization and the number of immunepositive parafollicular cells for calcitonin, which decreases blood Ca level by inhibiting bone resorption, did not remarkably differ. Parathyroid glands were similarly observed among all examined mice, and were surrounded by the connective tissues in thyroid glands (Figure 2(c) ). Similar to thyroid glands, no histopathological change including inflammation was observed within the parathyroid glands in all mice. Further, the localization and the number of immune-positive principal cells for PTH, increasing bone resorption, did also not remarkably differ.
Altered bone morphology in BXSB-Yaa
Macroscopically, during observation periods, the tibia of BXSB-Yaa were smaller, and BM was whiter compared to BXSB at six months (Figure 3(a) ) as associating with the ............................................................................................................................................................ increased WBCs and anemic phenotypes of BXSB-Yaa (Figure 1(g) , (l) and (n)). The tibia length and the weight of tibia and fibula significantly increased in BXSB with advancing age, but an age-related significant increase in BXSB-Yaa was only observed in the tibia length (Figure 3  (b) and (c) ). Importantly, BXSB-Yaa exhibited significantly shorter and lighter tibia compared to BXSB at six months (Figure 3(b) and (c)) . Further, the ratio of tibia and fibula weight to BW in BXSB-Yaa at six months was significantly lower than in the same strain at three months or BXSB at six months (Figure 3(d) ).
Regarding the histopathological analysis of the tibias, we observed entire bone sections and identified drastic morphological changes around the epiphysis in BXSBYaa. Briefly, although no remarkable strain difference was observed at three months, the reduction of trabeculas and thinning of compact bone was observed in BXSB-Yaa at six months (Figure 3(e) ). In the area ratio of bone to BM, an indicator of bone thickness, BXSB-Yaa showed significantly lower values compared with BXSB at six months (Figure 3  (f) ). Further, to evaluate trabecular bones, we examined Tb. Ar/T.Ar, Tb.Wi, Tb.N, and Tb.Sp, according to a parallel plate model (Figure 3 (g) to (j)). 25, 26 Regarding the values of Tb.Ar/T.Ar, Tb.Wi, and Tb.N, BXSB-Yaa at six months of age showed significantly lower values compared with the same strain at three months or BXSB at six months of age, and Tb.Wi in BXSB-Yaa at three months was also significantly lower than BXSB at the same age (Figure 3 (g) to (j) ). Additionally, BXSB-Yaa at six months of age showed significantly higher values in Tb.Sp compared with BXSB-Yaa at three months and BXSB at six months of age (Figure 3 (j) ). However, no significant difference was observed in the density of osteocytes between the strains at both examined ages (Figure 3(k) ).
Altered number of osteogenesis-associated cells in BXSB-Yaa
To evaluate osteoclasts, we observed the cells positive for TRAP, the enzyme produced by osteoclasts. 27 TRAP þ osteoclasts were mainly localized to the surface of the medullary cavity, and were more abundant near the epiphyseal cartilages in both strains at both ages (Figure 4(a) ). However, the enzyme activity of TRAP seemed to be stronger in BXSBYaa at six months compared with other mice. These findings were confirmed by histoplanimetry, displaying that the number of TRAP þ osteoclasts was higher in BXSB-Yaa than in BXSB at both ages, and significant difference was observed at six months (Figure 4(c) ).
Subsequently, we also evaluated osteoblasts by immunohistochemistry targeting the osteocalcin produced by osteoblasts, which is generally regarded as a marker of bone formation. 28 Similar to TRAP þ osteoclasts, the osteocalcin þ cells lined the surface of the medullary cavity (Figure 4(b) ). There were no age-or strain-related differences in the numerical values of osteoblasts. However, BXSB-Yaa tended to display lower values compared to BXSB at three months of age, and subsequently tended to increase with advancing age, in the osteocalcin þ osteoblasts (Figure 4(d) ).
mRNA expression of Yaa locus genes and inflammatory cytokines in BXSB-Yaa
In order to identify the factors associated with autoimmune disease and bone abnormalities, the mRNA expression of the humerus including BM was examined by qPCR. Firstly, we examined the genes on the Yaa locus ( Figure 5 ), since BXSB-Yaa had the duplicated 15 genes on Y chromosome because of translocation of X chromosome. 19 The genes, such as Rab9, member of the RAS oncogene family (Rab9), tymosin b 4 X chromosome (Tmsb4x), phosphoribosyl pyrophosphate synthetase 2 (Prps2), toll-like receptor 7 (Tlr7), and Tlr8, were higher in BXSB-Yaa compared with BXSB at three and six months of ages without age-related ............................................................................................................................................................ changes. Thus, the expression of the genes seemed to be increased by the influence of Yaa mutation. Further, BXSB-Yaa significantly showed higher expression in MSL complex subunit 3 (Msl3) and Rho GTPase activating protein 6 (Arhgap6) compared with BXSB at six months and BXSB-Yaa at three months. An age-related significant increase was observed in the expression of amelogenin X-linked (Amelx) in BXSB-Yaa, and this strain at six ............................................................................................................................................................ months also significantly showed higher expression in Midline 1 (Mid1) than BXSB at the same age.
Consequently, the mRNA levels of inflammatory cytokines associating with bone resorption, such as Il1a, Il1b, Il6, Il8, and Tnf, were measured ( Figure 5) . [10] [11] [12] 29 The expression of Il1a and Tnf in BXSB-Yaa at six months was significantly higher than in BXSB at six months and in BXSB-Yaa at three months. Furthermore, the mRNA levels of Il1b in both strains at six months were higher than that at three months, and the increase of BXSB-Yaa was more significant.
Correlation between altered bone morphology and autoimmune disease in BXSB-Yaa
Correlation between the indices of bone morphology and autoimmune disease is shown in Table 1 . The ratio of tibia and fibula weight to BW in all mice showed significant and negative correlations with S/B and mRNA expression of Tlr8 and Tlr7 in bones; and that in BXSB-Yaa showed significant and negative correlations with Arhgap6 expression in bones. The area ratio of bone to BM showed significant and negative correlations with serum anti-dsDNA antibody levels and mRNA expression of Rab9, Tmsb4x, Prps2, Msl3, Arphgap6, and Mid1 in bones; and that in BXSB-Yaa showed significant and negative correlations with Tmsb4x, Prps2, and Msl3 expression in bones. Tb.Ar/ T.Ar showed significant and negative correlations with S/B, serum anti-dsDNA antibody levels, and mRNA expression of Tmsb4x, Tlr7, Tlr8, Prps2, Msl3, Arphgap6, Figure 5 . mRNA expression of Yaa locus genes and inflammatory cytokines in the bones of mice. The genes on Yaa locus, such as Rab9, Tmsb4x, Tlr8, Tlr7, and Prps2, are higher in BXSB-Yaa compared with BXSB at both ages. Additionally, BXSB-Yaa at six months also significantly shows higher expression in Msl3 and Arhgap6 compared with BXSB and BXSB-Yaa at three months, respectively. Age-related significant increase is observed in the expression of Amelx in BXSB-Yaa, and this strain at six months also significantly shows higher expression in Mid1 than BXSB. The mRNA levels of inflammatory cytokines, such as Il1a and Tnf, in BXSB-Yaa at six months are significantly higher than in BXSB at the same age and in BXSB-Yaa at three months. Further, an age-related significant increase is observed in the mRNA levels of Il1b in both strains. BXSB: BXSB/MpJ. BXSB-Yaa: BXSB/MpJ-Yaa. The number of samples used in the studies is as follows: n ¼ 5-15. Each bar represents the mean AE SE. *Significance with the other strain at the same age (Mann-Whitney U-test, *P < 0.05, **P < 0.01). † Significance with the same strain at other ages (Mann-Whitney U-test, † P < 0.05, † † P < 0.01). (A color version of this figure is available in the online journal.) and Il1b in bones, and that in BXSB-Yaa showed significant and negative correlations with S/B and Il1a and Il1b expression in bones. Tb.Wi showed significant and negative correlations with S/B, serum anti-dsDNA antibody levels, and the mRNA expression of Rab9, transcription elongation factor A (SII) N-terminal and central domain (Tceanc), Tmsb4x, Tlr7, Tlr8, Prps2, holocytochrome c synthase (Hccs), Il1a, and Il1b in bones, and that of BXSB-Yaa showed significant and negative correlations with oralfacial digital syndrome 1 (Ofd1), Rab9, Tmsb4x, Il1a, and Il6 expression. The number of TRAP þ osteoclasts showed significant and positive correlations with S/B, serum antidsDNA antibody levels, and mRNA expression of Tlr8, Msl3, Arhgap6, and Mid1 in bones; and that in BXSB-Yaa showed significant and positive correlations with Rab9 expression in bones. The numerical values of osteocalcin þ osteoblast area showed significant and positive correlations with mRNA expression of Amelx in bones, and that in BXSB-Yaa showed significant and negative correlations with the Tlr7 expression in bones.
Discussion
We clarified that the autoimmune disease-prone BXSB-Yaa had higher level of serum Ca at two to four months. Ca serum level is an indicator of bone metabolism, and Spearman's rank correlation coefficients: *P < 0.05, **P < 0.01, n ! 4.
hypercalcemia is predominantly caused by osteoclast activation as found in human osteoporosis with advancing age or menopause. 30, 31 In fact, BXSB-Yaa showed an increase in the number of TRAP þ osteoclasts from three months. Further, at six months, the serum level and urinary excretion of Ca in BXSB-Yaa significantly decreased and increased, respectively, with the progression of autoimmune disease phenotypes including nephritis. Although the renal tubules play a crucial role in the Ca reabsorption from primitive urine, the Ca could not be reabsorbed through renal tubules in aged BXSB-Yaa because of renal injury. Notably, secondary renal hyperparathyroidism was observed to develop to compensate the increased urinary loss of Ca in the CKD patients. 16 However, there was no change in the serum PTH level as well as the morphologies of thyroid and parathyroid glands in BXSB-Yaa during the examined periods. Importantly, in aged BXSB-Yaa, the tibia length and the weight of tibia and fibula were observed to significantly decrease compared with BXSB. Therefore, altered Ca dynamics in BXSB-Yaa suggested that their osteoclast number was increased and activated via a PTH-independent mechanism as a direct consequence of autoimmune disease or Yaa mutations to bone metabolism.
Previous studies have reported the development of hemolytic anemia, one of the causes of osteoporosis, in mice carrying Yaa mutations. 32 Here, we also revealed that aged BXSB-Yaa showed higher and lower values in MCV and MCHC, respectively compared to BXSB. However, number of RBCs and Ht was comparable between both strains. A high value of MCV signifies the production of large and immature RBCs including reticulocytes in response to anemia. 33 MCHC indicated the hemoglobin concentration in RBC; generally, a reduced MCHC was followed by a decrease in the MCV as found in microcytic hypochromic anemia because of iron deficiency. 33 Alternatively, the altered patterns of MCV and MCHC in BXSB-Yaa were not typical cases of anemia. Importantly, we also found significantly increased numbers of WBCs and decreased PLs in aged BXSB-Yaa. Therefore, these data reflect that the altered hematopoiesis, such as abnormal lymphocyte production as shown in the previous study about human multiple myeloma, 34 might also affect the values of hemoanalysis and BM morphology in BXSB-Yaa.
BXSB-Yaa tended to show an increase in osteoclasts and decrease in osteoblasts in the tibia at three months. These altered populations to bone resorption patterns would be associated with the increased serum Ca level in BXSB-Yaa. Further, a sustained increase in osteoclast number from three to six months would be critical for the abnormal remodeling of bones, as characterized by significant reduction in bone length, weight, and trabeculas at six months. Importantly, the osteocyte number was not altered, however, the bone area was reduced in the tibia of BXSB-Yaa during periods of observation, indicating total decrease of osteocytes, important cells for mineral metabolism. 35 Along with PTH, inflammatory cytokines including IL-1, IL-6, and TNF-a can activate osteoclasts as found in the patients with RA and osteoporosis. [10] [11] [12] However, these cytokines were not significantly correlated with the indices for bone morphology and osteoclast numbers in the present study.
Notably, in BXSB-Yaa, the numerical values of osteoblasts was rescued at six months of age. However, the functional maturation was not clear in the increased numerical values of osteoblasts in BXSB-Yaa. Thus, the hyperimmune status in BM would be induced by autoimmune abnormality, and it might indirectly affect the function and/or population of cells-associating bone remodeling in BXSB-Yaa. Importantly, similar pathological alterations characterized by the loss of bone tissue due to imbalance between osteoclasts and osteoblasts were observed in the osteoporosis patients. 6 The patients of autoimmune disease also develop osteoporosis, for example, RA in humans causes secondary osteoporosis due to inflammatory cytokines, medicine, or immobilization. 36 Therefore, BXSB-Yaa would be a suitable model to analyze the altered bone remodeling due to autoimmune abnormalities.
The causative factors of autoimmune disorder in BXSBYaa were encoded on the Yaa locus. 19 We examined the expression of all 15 protein-coding genes on this locus to discuss their pathological contributions of autoimmunity and bone morphology. At three months, Rab9, Tmsb4x, Prps2, Tlr7, and Tlr8 were highly expressed in BXSB-Yaa bones. There was no relation between Rab9 and autoimmunity. However, this gene was associated with osteoclast function to secrete lysosomal enzymes in rats. 37 Tmsb4x is a diagnostic indicator of osteoporosis or a regulator of the differentiation of hematopoietic cells in humans, 38, 39 and these genes were also significantly correlated with the indices of bone area in BXSB-Yaa. Prps2 also significantly correlated with the indices of bone area in BXSB-Yaa, and the variants of Prps2 genes were associated with the development of SLE in humans, 40 however, there is no report on the bone. Furthermore, the associations of TLR7 or 8 and autoimmune abnormalities were well analyzed in BXSBYaa, 22, 41 and the roles of candidate genes in developing SLE-like symptoms including nephritis were suggested. TLR7 was associated with RA by contributing to produce inflammatory cytokines, such as IL-1, IL-6, and TNF-a, from macrophages in mice. 42, 43 TLR8 may have a role in human RA, however, the detailed function of murine TLR8 is unclear. 44 Therefore, these genes would be candidates to develop the autoimmune disease and/or following bone abnormalities.
The expression of Msl3, Arhgap6, Amelx and Mid1 on Yaa locus significantly increased with the progression of the autoimmune disease. However, there is no evidence between Msl3 or Mid1 and autoimmunity or bones, but Mid1 seemed to be associated with activating the innate immune pathway in allergic asthma. 45 Alternatively, human Arhgap6, activating the Ras homolog gene family, member A (RhoA), 46 and Amelx in mice seemed to act as the mediator of osteoblasts and osteoclasts-genesis, respectively. 47, 48 Therefore, these genes would deteriorate autoimmune disease and/or bone abnormalities as exacerbating factors.
There were neither age-nor strain-related differences in the expression of Ofd1, Tceanc, and Hccs. However, the expression of these genes had significant and negative correlation with Tb.Wi. Additionally, Ofd1 seemed to be associated with endochondral skeletal development, 49 although there is no report of the evidence between Tceanc or Hccs and autoimmunity or bone study. Thus, these genes might also contribute to bone abnormality. We have demonstrated that systemic autoimmune disease in BXSB-Yaa is closely associated with the morphofunctional abnormalities of bones including BM. The abnormalities are characterized by altered regulations of serum Ca, anemia tendency, and hematopoiesis with increased WBCs and decreased PLs, short length and low mass of long bones, imbalance in the populations of osteoclasts and osteoblasts, and increased expression of candidate genes for causing and/or exacerbating their phenotypes. Therefore, as shown in BXSB-Yaa, we concluded that the bone phenotypes in systemic autoimmune disease would elaborately be affected by the factors in the bone as well as the other immune and/or mineral metabolism organs.
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